WATCH-DM Score Tracks Mortality Risk in T2DM Without HF Tags Coronary artery disease Read more about WATCH-DM Score Tracks Mortality Risk in T2DM Without HF
Overlooked HbA1c Levels Highlight Risk in ACS Tags Coronary artery disease Heart disease hBA1c Read more about Overlooked HbA1c Levels Highlight Risk in ACS
Canagliflozin Modifies Sodium-Heart Failure Risk Pattern in T2DM-CKD Tags Coronary artery disease SGLT-2 Inhibitor Read more about Canagliflozin Modifies Sodium-Heart Failure Risk Pattern in T2DM-CKD
GLP-1-Based Therapies Show Distinct CV and Renal Effects in T2DM Tags Coronary artery disease Myocardial infarction GLP-1 agonists DPP-4 inhibitors Read more about GLP-1-Based Therapies Show Distinct CV and Renal Effects in T2DM
Lower eGDR Levels Indicate Higher Vascular Event Risk in T2DM Tags Coronary artery disease Myocardial infarction hBA1c Read more about Lower eGDR Levels Indicate Higher Vascular Event Risk in T2DM
Higher Basal Metabolic Rate Linked to Diabetes Risk in Cohort Tags CRP Diabetic ketoacidosis Diabetic coma Coronary artery disease Stroke hBA1c Read more about Higher Basal Metabolic Rate Linked to Diabetes Risk in Cohort
Lower MACE Rates Seen With Tirzepatide vs Dulaglutide in T2DM Tags Coronary artery disease Myocardial infarction Stroke GLP-1 agonists Read more about Lower MACE Rates Seen With Tirzepatide vs Dulaglutide in T2DM
GLP-1 RAs Show Lower Mortality in RA With Type 2 Diabetes Tags Diabetic Nephropathy Coronary artery disease Myocardial infarction GLP-1 agonists DPP-4 inhibitors Read more about GLP-1 RAs Show Lower Mortality in RA With Type 2 Diabetes
GLP-1 RAs Show Lower CV Event Risk Than SGLT2is in MASLD With T2DM Tags Coronary artery disease Stroke GLP-1 agonists SGLT-2 Inhibitor Read more about GLP-1 RAs Show Lower CV Event Risk Than SGLT2is in MASLD With T2DM
Lower HRV Associated With Greater Arterial Stiffness Across Glycemia Tags Coronary artery disease Read more about Lower HRV Associated With Greater Arterial Stiffness Across Glycemia